My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 3 Dec 2009 | 1:06 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Harvard Bioscience Inc
Harvard Bioscience Inc (HBIO.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Medical Equipment, Supplies & Distribution
ยท
View
HBIO
on other exchanges
As of 2 Dec 2009
3.60
USD
Price Change
-0.03
Percent Change
-0.83%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Green, David
44
1996
President, Director
Lewis, Earl
65
2008
Lead Director
Dishman, Robert
64
2000
Director
Kennedy, John
60
2000
Director
Harte, Neal
65
2004
Director
Uveges, George
61
2006
Director
Luscinski, Susan
52
2008
Chief Operating Officer
McNaughton, Thomas
48
2008
Chief Financial Officer, Treasurer
Graziano, Chane
70
1996
Chairman of the Board, Chief Executive Officer
Find out more about HBIO.O
Insider Trading